Product
esmolol
1 clinical trial
7 indications
Indication
SepsisIndication
Lymphocyte Disorder TIndication
Immunologic ParalysisIndication
Catecholamine overproductionIndication
Beta-BlockerIndication
Cytokine StormIndication
Sympathetic Nervous System DiseasesClinical trial
Investigating the Immunomodulatory Effects of Esmolol in Sepsis Management and Its Impact on Patient OutcomesStatus: Completed, Estimated PCD: 2023-12-31